Iconic Australian beer manufacturer Carlton & United Breweries has lost an appeal seeking to shield information about 1,500 allegedly privileged documents from the Australian Taxation Office.
Qantas has lost its second attempt to delay a hearing on further relief pending an appeal in its outsourcing spat with the Transport Workers Union, with a judge finding a stay would prejudice the union more than the airline.
A Western Australia Supreme Court judge has dodged a lawsuit by a kosher compliance inspector who alleged he was defamed by an email that claimed the inspector did not have “shem tov”, or a good name, in Perth’s Jewish community.
Qantas has filed a bid to delay a hearing on penalty after a judge found the airline outsourced ground operations partly to prevent employees engaging in industrial action, but the TWU has said a stay would be āunfairā to 1,600 former ground staff.
Avant Insurance has lost a bid to pause an order that it pay $371,000 in the legal costs of a surgeon facing a class action by breast implant patients of defunct clinic the Cosmetic Institute while the insurer’s appeal is pending.
Federal environment minister Sussan Ley has approved a controversial coal mining project that is expected to release 100 million tonnes of carbon dioxide into the Earthās atmosphere, despite a landmark ruling that the government has a duty of care to consider the impact of fossil fuel projects on the next generation of Australians.
Clive Palmer’s Mineralogy has appealed a ruling tossing a lawsuit it brought against ASIC, which a judge called an “ill-disguised collateral attack” on the regulator for criminal proceedings against the billionaire mining magnate over $12 million in payments made to his political party in 2013.
Sportswear brand Puma has launched an appeal against a Federal Court decision that found itās āProcatā trade mark was deceptively similar to US machinery manufacturer Caterpillarās CAT marks.
Approximately 1,000 investors of collapsed stockbroker Halifax Investment Services have challenged a court decision concerning the date of the realisation of their investments which decreased the amounts they could recoup from the company’s liquidation.
Merck Sharp & Dohme is seeking to overturn a judgment refusing an extension of a patent covering its Januvia and Janumet diabetes drugs that would have seen the US drug maker of retaining a monopoly over the multibillion dollar medicines beyond July 2022.